Edgewise Therapeutics (EWTX) PT Raised to $25 at JPMorgan
Tweet
Share
E-mailGet Alerts EWTX Hot Sheet
Price: $36.21 -2.79%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
JPMorgan analyst Tessa Romero raised the price target on Edgewise Therapeutics (NASDAQ: EWTX) to $25.00 (from $24.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Edgewise Therapeutics (EWTX) PT Lowered to $48 at RBC Capital
- Goldman Sachs Upgrades Plains All American (PAA) to Neutral
- BorgWarner (BWA) PT Raised to $95 at Wolfe Research, 'Bullish Takeaways from CEO Meetings'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
